Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Нервные болезни
2019 / N 1

Цереброваскулярная патология и диабетическая полиневропатия при сахарном диабете: общность патогенетических механизмов и подходы к ведению пациентов
К.В. Антонова, О.В. Лагода, М.М. Танашян

References

1. American Diabetes Association. 10. Cardiovascular disease and risk management: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019 Jan;42(Suppl 1):S103-S123.
2. Dedov II, Shestakova MV, Vikulova OK, Zheleznyakova AV, Isakov MA. Diabetes mellitus in Russian Federation: prevalence, morbidity, mortality, parameters of clicaemic control and structure of glucose lowering therapy according to the Federal diabetes register, status 2017. Diabetes Mellitus 2018;21(3):144-59 (In Russian).
3. Luitse MJ, Biessels GJ, Rutten GE, Kappelle LJ. Diabetes, hyperglycaemia, and acute ischaemic stroke. The Lancet. Neurology 2012 Mar;11(3):261-71.
4. Akhtar N, Kamran S, Singh R, Malik RA, Deleu D, Bourke PJ, Joseph S, Santos MD, Morgan DM, Wadiwala FM, Francis R, Babu BM, George P, Ibrahim R, Garcia-Bermejo P, Shuaib A. The impact of diabetes on outcomes after acute ischemic stroke: a prospective observational study. Journal of Stroke Cerebrovascular Disease 2019 Mar;28(3):619-26.
5. Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nature Reviews. Endocrinology 2018 Oct;14(10):591-604.
6. Li WA, Moore-Langston S, Chakraborty T, Rafols JA, Conti AC, Ding Y. Hyperglycemia in stroke and possible treatments. Neurological Research 2013 Jun;35(5):479-91.
7. Dedov II, Shestakova MV. "Metabolic memory" phenomenon in predicting risk of vascular complications in diabetes mellitus. Therapeutic Archive 2015;87(10):4-10 (In Russian).
8. Balabolkin MI, Petunina NA, Telnova ME, Klebanova EM, Antonova KV. Insulin therapy in diabetes mellitus compensation. Russian Medical Journal 2007;15(27):2072-8 (In Russian).
9. Rhee SY, Kim YS. The role of advanced glycation end products in diabetic vascular complications. Diabetes & Metabolism Journal 2018 Jun;42(3):188-95.
10. Saad MI, Abdelkhalek TM, Saleh MM, Kamel MA, Youssef M, Tawfik SH, Dominguez H. Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells. Endocrine 2015 Dec;50(3):537-67.
11. Liu L, Zhan L, Wang Y, Bai C, Guo J, Lin Q, Liang D, Xu E. Metabolic syndrome and the short-term prognosis of acute ischemic stroke: a hospital-based retrospective study. Lipids in Health and Disease 2015 Jul;14(1):76.
12. Elgebaly MM, Arreguin J, Storke N. Targets, treatments, and outcomes updates in diabetic stroke. Journal of Stroke and Cerebrovascular Diseases 2019. [Epub ahead of print].
13. Mizuma A, Yenari MA. Anti-inflammatory targets for the treatment of reperfusion injury in stroke. Frontiers in Neurology 2017 Sep;8:467.
14. Zhao Z, Hu J, Gao X, Liang H, Yu H, Liu S, Liu Z. Hyperglycemia via activation of thromboxane A2 receptor impairs the integrity and function of blood-brain barrier in microvascular endothelial cells. Oncotarget 2017 May;8(18):30030-8.
15. Posada-Duque RA, Barreto GE, Cardona-Gomez GP. Protection after stroke: cellular effectors of neurovascular unit integrity. Frontiers in Cellular Neuroscience 2014 Aug;8:231.
16. Wang H, Cheng Y, Chen S, Li X, Zhu Z, Zhang W. Impact of elevated hemoglobin A1c levels on functional outcome in patients with acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases 2019;28:470-6.
17. Antonova KV, Tanashyan MM, Romantsova TI, Maksimova MYu. Acute stroke: clinical course and prognosis in patients with type 2 diabetes mellitus. Obesity and Metabolism 2016;13(2):20-4 (In Russian).
18. Zheng Z, Wu J, Wang R, Zeng Y. Diabetes mellitus may induce cardiovascular disease by decreasing neuroplasticity. Functional Neurology 2014 Jan-Mar;29(1):7-13.
19. Suslina ZA, Tanashyan MM, Ionova VG. Ischemic stroke: blood, blood vessel wall and antiplatelet therapy. Moscow: Meditsinskaya kniga; 2005. 248 p. (In Russian).
20. Pomero F, Di Minno MND, Fenoglio L, Gianni M, Ageno W, Dentali F. Is diabetes a hypercoagulable state? A critical appraisal. Acta Diabetologica 2015;52:1007-16.
21. Tanashyan MM, Antonova KV, Shabalina AA, Lagoda OV, Romantsova TI. Нaemostasis and carbohydrate metabolism in patients with diabetes mellitus type 2 and cerebrovascular diseases. Tromboz, Gemostaz i Reologiya 2018;4(76):16-23 (In Russian).
22. Levin OS. Polyneuropathies. Clinical guidelines. Moscow: MIA; 2016. 480 p. (In Russian).
23. llarioshkin SN, Dadali EL, Fedotov VP, Ismayilov ShM, Klyushnikov SA, Pirogov VN, Ivanova-Smolenskaya IA. New form of hereditary neuropathy: Charcot-Marie–Tooth disease type 2F. Atmosphere. Nervous Diseases 2005;2:42-6 (In Russian).
24. Murtazina AF, Shchagina OA, Nikitin SS, Dadali EL, Polyakov AV. Current views on phenotypic and genetic features of autosomal recessive hereditary peripheral neuropathies. Annals of Clinical and Experimental Neurology 2019;1:55-69 (In Russian).
25. Unmar Y, Zafar MI, Gao F. Factors associated with peripheral neuropathy in type 2 diabetes: subclinical versus confirmed neuropathy. Journal of Huazhong University of Science and Technology. Medical Science 2017 Jun;37(3):337-42.
26. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. ACC/AHA guideline on the primary prevention of cardiovascular disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Journal of American College of Cardiology 2019 Mar 17. pii: S0735-1097(19)33876-8. doi: 10.1016/j.jacc.2019.03.009. [Epub ahead of print].
27. Bruschi LKM, da Rocha DA, Filho ELG, Barboza NMP, Frizanco PAB, Gallegaro RM, de Sá LBPC, Arbex AK. Diabetes mellitus and diabetic peripheral neuropathy. Open Journal of Endocrine and Metabolic Diseases 2017 Jan;7:12-21.
28. Marso SP, Kennedy KF, House JA, McGuire DK. The effect of intensive glucose control on all‐cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta‐analysis. Diabetes and Vascular Disease Research 2010 Apr;7(2):119‐30.
29. Fang HJ, Zhou YH, Tian YJ, Du HY, Sun YX, Zhong LY. Effects of intensive glucose lowering in treatment of type 2 diabetes mellitus on cardiovascular outcomes: a meta‐analysis of data from 58,160 patients in 13 randomized controlled trials. International Journal of Cardiology 2016 Sep;218:50‐8.
30. Diabetes Control and Complications Trial Research Group; Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 1993 Sep;329(14):977-86.
31. Ang L, Jaiswal M, Martin C, Pop-Busui R. Glucose control and diabetic neuropathy: lessons from resent large clinical trials. Current Diabetes Reports 2014;14(9):528.
32. Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. The Lancet. Neurology 2012 Jun;11(6):521-34.
33. Elsherbiny NM, Al-Gayyar MM, Abd-El Galil KH. Nephroprotective role of dipyridamole in diabetic nephropathy: effect on inflammation and apoptosis. Life Sciences 2015 Dec;143:8-17.
34. Sharma AK, Khanna D, Balakumar P. Low-dose dipyridamole treatment partially prevents diabetes mellitus-induced vascular endothelial and renal abnormalities in rats. International Journal of Cardiology 2014 Mar;172(2):530-2.
35. Suslina ZA, Tanashyan MM, Domashenko MA. Antiplatelet therapy of ischemic disorders of cerebral circulation. Moscow: MIA; 2009. 224 p. (In Russian).
36. Tanashyan MM, Domashenko MA. Dipyridamole in complex therapy of chronic cerebrovascular diseases. Nervous Diseases 2012;3:27-30 (In Russian).
37. Konrad T, Vicini P, Kusterer K, Höflich A, Assadkhani A, Böhles HJ, Sewell A, Tritschler HJ, Cobelli C, Usadel KH. Alpha-lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 1999 Feb;22(2):280-7.
38. Rochette L, Ghibu S, Muresan A, Vergely C. Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Canadian Journal of Physiology and Pharmacology 2015 Dec;93(12):1021-7.
39. Ziegler D. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treatments in Endocrinology 2004;3(3):173-89.
40. Ziegler D, Low PA, Boulton AJM. Effect of a 4-year antioxidant treatment with alpha-lipoic acid in diabetic polyneuropathy: the NATHAN-1 trial. In: Proceedings of the 67th American Diabetes Association (ADA) Congress; 2007 Jun 22-26; Chicago, IL: Abstract 0007-OR.
41. Ibrahim A. IDF clinical practice recommendation on the diabetic foot: a guide for healthcare professionals. Diabetes Research and Clinical Practice 2017 May;127:285-7.
42. Bregovskiy VB, Hramilin VN, Demidova IYu, Strokov IA, Guryeva IV. Diabetic distal polyneuropathy. Review of current recommendations. Annals of Clinical and Experimental Neurology 2015;9(1):60-8 (In Russian).
43. Lu C, Maharjan S, Wang Q, Sun Y, Han X, Wang S, Mao Z, Xin Y, Zhang B. α-Lipoic acid promotes neurological recovery after ischemic stroke by activating the Nrf2/HO-1 pathway to attenuate oxidative damage. Cellular Physiology and Biochemistry 2017;43(3):1273-87.
44. Moura FA, de Andrade KQ, dos Santos JC, Goulart MO. Lipoic acid: its antioxidant and anti-inflammatory role and clinical applications. Current Topics in Medicinal Chemistry 2015;15(5):458-83.
45. Chaudhary P, Marracci G, Galipeau D. Pocius E, Morris B, Bourdett D. Lipoic acid reduces inflammation in a mouse focal cortical experimental autoimmune encephalomyelitis model. Journal of Neuroimmunology 2015 Dec;289:68-74.
46. Choi KH, Park MS, Kim HS, Kim KT, Kim HS, Kim JT, Kim BC, Kim MK, Park JT, Cho KH. Alpha-lipoic acid treatment is neurorestorative and promotes functional recovery after stroke in rats. Molecular Brain 2015 Feb;8:9.
47. Chang P, Liu J, Yu Y, Cui SY, Guo ZH, Chen GM, Huang Q, Liu ZG. Alpha-lipoic acid suppresses extracellular histone-induced release of the infammatory mediator tumor necrosis factor-α by macrophages. Cellular Physiology and Biochemistry 2017;42(6):2559-68.
48. Mohammadi V, Khorvash F, Feizi A, Askari G. Does alpha-lipoic acid supplementation modulate cardiovascular risk factors in patients with stroke? A randomized, double-blind clinical trial. International Journal of Preventive Medicine 2018;9:34.
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]